Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. AMD
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
(NASDAQ: ERNA) Delayed: 3.99 -0.46 (10.34%)
Previous Close $4.45    52 Week High $ 
Open $4.33    52 Week Low $ 
Day High $4.46    P/E N/A 
Day Low $3.97    EPS $ 
Volume 71,542